Title
LPG stove and fuel intervention among pregnant women reduce fine particle air pollution exposures in three countries: Pilot results from the HAPIN trial
Date Issued
15 December 2021
Access level
open access
Resource Type
journal article
Author(s)
Liao J.
Kirby M.A.
Pillarisetti A.
Piedrahita R.
Balakrishnan K.
Sambandam S.
Mukhopadhyay K.
Ye W.
Rosa G.
Majorin F.
Dusabimana E.
Ndagijimana F.
McCracken J.P.
Mollinedo E.
de Leon O.
Díaz-Artiga A.
Thompson L.M.
Kearns K.A.
Naeher L.
Rosenthal J.
Clark M.L.
Steenland K.
Waller L.A.
Checkley W.
Peel J.L.
Clasen T.
Johnson M.
Aravindalochanan V.
Bankundiye G.
Barr D.B.
Canuz E.
Castañaza A.
Chen Y.
Craik R.
Davila-Roman V.G.
de las Fuentes L.
Elon L.
Espinoza J.G.
Garg S.
Hamid S.
Harvey S.A.
Hengstermann M.
Hennessee I.
Herrera P.M.
Hossen S.
Howards P.P.
Jaacks L.
Jabbarzadeh S.
Lenzen P.
Lovvorn A.E.
Mbabazi J.
McCollum E.
Meyers R.
Moulton L.
Mukeshimana A.
Mutariyani B.
Natesan D.
Nizam A.
Ntivuguruzwa J.d.D.
Papageorghiou A.
Puttaswamy N.
Puzzolo E.
Quinn A.
Rajamani K.D.
Ramakrishnan U.
Ramasami R.
Ramirez A.
Ryan P.B.
Saidam S.
Sarnat J.A.
Simkovich S.
Sinharoy S.S.
Smith K.R.
Swearing D.
Thangavel G.
Toenjes A.
Valdes V.
Young B.N.
Publisher(s)
Elsevier B.V.
Abstract
The Household Air Pollution Intervention Network trial is a multi-country study on the effects of a liquefied petroleum gas (LPG) stove and fuel distribution intervention on women's and children's health. There is limited data on exposure reductions achieved by switching from solid to clean cooking fuels in rural settings across multiple countries. As formative research in 2017, we recruited pregnant women and characterized the impact of the intervention on personal exposures and kitchen levels of fine particulate matter (PM2.5) in Guatemala, India, and Rwanda. Forty pregnant women were enrolled in each site. We measured cooking area concentrations of and personal exposures to PM2.5 for 24 or 48 h using gravimetric-based PM2.5 samplers at baseline and two follow-ups over two months after delivery of an LPG cookstove and free fuel supply. Mixed models were used to estimate PM2.5 reductions. Median kitchen PM2.5 concentrations were 296 μg/m3 at baseline (interquartile range, IQR: 158–507), 24 μg/m3 at first follow-up (IQR: 18–37), and 23 μg/m3 at second follow-up (IQR: 14–37). Median personal exposures to PM2.5 were 134 μg/m3 at baseline (IQR: 71–224), 35 μg/m3 at first follow-up (IQR: 23–51), and 32 μg/m3 at second follow-up (IQR: 23–47). Overall, the LPG intervention was associated with a 92% (95% confidence interval (CI): 90–94%) reduction in kitchen PM2.5 concentrations and a 74% (95% CI: 70–79%) reduction in personal PM2.5 exposures. Results were similar for each site. Conclusions: The intervention was associated with substantial reductions in kitchen and personal PM2.5 overall and in all sites. Results suggest LPG interventions in these rural settings may lower exposures to the WHO annual interim target-1 of 35 μg/m3. The range of exposure contrasts falls on steep sections of estimated exposure-response curves for birthweight, blood pressure, and acute lower respiratory infections, implying potentially important health benefits when transitioning from solid fuels to LPG.
Volume
291
Language
English
OCDE Knowledge area
Ciencias del medio ambiente
Scopus EID
2-s2.0-85116506611
PubMed ID
Source
Environmental Pollution
ISSN of the container
0269-7491
Sponsor(s)
The HAPIN trial is funded by the U.S. National Institutes of Health (cooperative agreement 1UM1HL134590 ) in collaboration with the Bill & Melinda Gates Foundation [ OPP1131279 ]. The HAPIN trial is funded by the U.S. National Institutes of Health (cooperative agreement 1UM1HL134590 ) in collaboration with the Bill & Melinda Gates Foundation [ OPP1131279 ]. The HAPIN trial is funded by the U.S. National Institutes of Health (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation [OPP1131279]. We would like to express our deep and sincere gratitude to the households that graciously invited us into their homes for this study. We also would like to thank the field teams, which worked diligently to collect the data presented here. A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Nancy R Cook, Stephen Hecht, Catherine Karr (Chair), Joseph Millum, Nalini Sathiakumar, Paul K Whelton, Gail G Weinmann (Executive Secretary). Program Coordination: Gail Rodgers, Bill & Melinda Gates Foundation; Claudia L Thompson, National Institute of Environmental Health Science; Mark J. Parascandola, National Cancer Institute; Marion Koso-Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Joshua P Rosenthal, Fogarty International Center; Conception R Nierras, NIH Office of Strategic Coordination Common Fund; Katherine Kavounis, Dong- Yun Kim, Antonello Punturieri, and Barry S Schmetter, NHLBI. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services. The study protocol has been reviewed and approved by institutional review boards (IRBs) or Ethics Committees at Emory University (00089799), Johns Hopkins University (00007464), Sri Ramachandra Institute of Higher Education and Research (IEC-N1/16/JUL/54/49) and the Indian Council of Medical Research ? Health Ministry Screening Committee (5/8/4?30/(Env)/Indo-US/2016-NCD-I), Universidad del Valle de Guatemala (146-08-2016) and Guatemalan Ministry of Health National Ethics Committee (11?2016), the London School of Hygiene and Tropical Medicine (11664?5) and the Rwandan National Ethics Committee (No.357/RNEC/2018), and Washington University in St. Louis (201611159). The HAPIN trial has been registered with ClinicalTrials.gov (Identifier NCT02944682). +HAPIN Investigators: Vigneswari Aravindalochanan, Gloriose Bankundiye, Dana Boyd Barr, Alejandra Bussalleu, Devan Campbell, Eduardo Canuz, Adly Casta?aza, Howard Chang, Yunyun Chen, Maril? Chiang, Rachel Craik, Victor G. Davila-Roman, Lisa de las Fuentes, Lisa Elon, Juan Gabriel Espinoza, Sarada Garg, Sarah Hamid, Stella Hartinger, Steven A. Harvey, Mayari Hengstermann, Ian Hennessee, Phabiola M. Herrera, Shakir Hossen, Penelope P. Howards, Lindsay Jaacks, Shirin Jabbarzadeh, Jacob Kremer, Pattie Lenzen, Amy E. Lovvorn, Jane Mbabazi, Eric McCollum, Rachel Meyers, Lawrence Moulton, Alexie Mukeshimana, Bernard Mutariyani, Durairaj Natesan, Azhar Nizam, Jean de Dieu Ntivuguruzwa, Aris Papageorghiou, Naveen Puttaswamy, Elisa Puzzolo, Ashlinn Quinn, Karthikeyan Dharmapuri Rajamani, Usha Ramakrishnan, Rengaraj Ramasami, Alexander Ramirez, P. Barry Ryan, Sudhakar Saidam, Jeremy A. Sarnat, Suzanne Simkovich, Sheela S. Sinharoy, Kirk R. Smith, Damien Swearing, Gurusamy Thangavel, Ashley Toenjes, Lindsay Underhill, Viviane Valdes, Kendra N. Williams, Bonnie N. Young. A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Nancy R Cook, Stephen Hecht, Catherine Karr (Chair), Joseph Millum, Nalini Sathiakumar, Paul K Whelton, Gail G Weinmann (Executive Secretary). Program Coordination: Gail Rodgers, Bill & Melinda Gates Foundation; Claudia L Thompson, National Institute of Environmental Health Science; Mark J. Parascandola, National Cancer Institute; Marion Koso-Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Joshua P Rosenthal, Fogarty International Center; Conception R Nierras, NIH Office of Strategic Coordination Common Fund; Katherine Kavounis, Dong- Yun Kim, Antonello Punturieri, and Barry S Schmetter, NHLBI. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services.
Sources of information: Directorio de Producción Científica Scopus